Search Results 1001-1010 of 15350 for alt

  1. A Study To Evaluate APG2575 Combined With Novel Therapeutic Regimens To Treat Subjects With Relapsed Or Refractory Multiple Myeloma And Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    AST and ALT < 3 x ULN (upper limit of normal);; Creatinine clearance > 30mL/min;; Bilirubin< 1.5 x ULN (Except if considered secondary to Gilbert's syndrome ...

  2. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

    Total bilirubin, AST, ALT, and alkaline phosphatase levels <2 times the upper limit of normal; Hemoglobin >7.0 gm/dL, white count >3.0 X 10(9), platelet ...

  3. Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - Mayo Clinic

    Alanine aminotransferase (ALT) ≤ 3 x ULN; Aspartate aminotransferase (AST) ≤ 3 x ULN; Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2 ...

  4. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes - Mayo Clinic

    Alanine aminotransferase (ALT) >2.0 × ULN,; Total bilirubin >1.5 × ULN with the exception of participants with the diagnosis of Gilbert's syndrome who may be ...

  5. STI-3031 Through Sofusa DoseConnect for Treatment of Intransit Melanoma - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤ 3.0 × ULN;; Serum creatinine ≤ 2.0 × ULN;; Calculated creatinine clearance ≥ 40 ml/min ...

  6. Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors - Mayo Clinic

    Serum aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) > 3 times upper limit of institutional normal. Gastrointestinal, or biliary ...

  7. CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin - Mayo Clinic

    AST(SGOT)/ALT(SGPT) ≤3 X ULN (including patients with liver metastases); Creatinine <1.5 X ULN; Cardiac ejection fraction >50% (by echocardiogram or MUGA) ...

  8. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

    ALT value > 5× the upper limit of normal (ULN) as defined by the central ... Evidence of significant worsening of ALT, AST or bilirubin during the ...

  9. T2 Lens Study - Mayo Clinic

    Significant renal dysfunction (eGFR < 45) or hepatic failure defined by elevated liver enzymes (AST above 36 U/L, ALT above 56 U/L). Participants with end ...

  10. Simplifying the Diagnosis of Bile Acid Malabsorption: Fasting Serum C4 and Proportion of Primary Bile Acids Measured from a Random, Single Stool Sample - Mayo Clinic

    ... ALT 2.0 X ULN; BA synthesis and possible false positive or negative fecal bile acid or serum 7alphaC4 result.no AST or ALT values in the medical record, the ...